PJX-31225-95089

Timeline

1. 2021-04-28
   Registered in v-safe
2. 2021-04-28
   Dose 1 — Pfizer-BioNTech
3. 2021-04-28
   Health check-in — day 0, dose 1

   Feeling: Fair · Site: Pain · Headache, Nausea

   Adult check-in
4. 2021-04-29
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · Site: Pain · None

   Adult check-in
5. 2021-04-30
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · None

   Adult check-in
6. 2021-05-02
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · None

   Adult check-in
7. 2021-05-04
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · None

   Adult check-in
8. 2021-05-15
   Survey response — day 14, dose 1

   MedDRA: Dry throat, Eye pruritus, Headache, Oropharyngeal pain, Pain, Pyrexia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

   Free text: Sore/Dry throat, dry nose, headaches, itchy eyes, low-grade fever, body aches

   MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
9. 2021-05-15
   Report sent to call center — day 14, dose 1

   Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

   1 call case(s)
10. 2021-05-20
    Dose 2 — Pfizer-BioNTech
11. 2021-05-26
    Health check-in — days 1–6 daily, dose 2

    Feeling: Good · None

    Adult check-in
12. 2021-06-03
    Call 1 — Could Not Reach Participant
13. 2021-06-08
    Call 2 — Could Not Reach Participant